Natera vs BeOne Medicines

Natera (NTRA), health care, and BeOne Medicines (ONC), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

BeOne Medicines is worth $47.2B on the stock market and Natera $41.7B: BeOne Medicines is valued at 13% more. Natera's operating margin in its latest fiscal year was -13.4% and BeOne Medicines's 8.37%. Over the past year Natera's share price has moved +35.0% and BeOne Medicines's +13.0%.

Key facts

Natera market value
$41.7B
BeOne Medicines market value
$47.2B
BeOne Medicines P/E
53.0
Natera revenue
$2.3BFY to 2025-12-31
BeOne Medicines revenue
$5.3BFY to 2025-12-31
Superinvestors holding both
1

Market values as of .

Natera vs BeOne Medicines: every measure side by side
Measure Natera BeOne Medicines
SectorHealth CareHealth Care
Country United States Switzerland
Fiscal year ends2025-12-312025-12-31
Size
Market cap$41.7Blower$47.2Bhigher
Revenue$2.3Blower$5.3Bhigher
Earnings-$208.2Mlower$286.9Mhigher
Employees6,135lower12,000higher
Total assets$2.4Blower$8.2Bhigher
Valuation
P/E—53.0
P/S18.1higher8.8lower
P/B22.2—
Dividend yield0.00%—
Profitability
Operating margin-13.4%lower8.37%higher
Balance sheet
Net assets$1.7Blower$4.4Bhigher
Total liabilities$685.9Mlower$3.8Bhigher
Total debt—$1B
Cash on hand$1.1Blower$4.5Bhigher
Price change
Today-0.35%lower+0.48%higher
1 year+35.0%higher+13.0%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Percentages are each holding's share of that investor's reported portfolio (under "Both": Natera / BeOne Medicines). Who owns NTRA · Who owns ONC

Further comparisons

Learn

Questions and answers

Which is bigger, Natera or BeOne Medicines?

By market value, BeOne Medicines is the larger: $47.2B against $41.7B for Natera. By revenue in its latest fiscal year, BeOne Medicines is the larger: $5.3B against $2.3B for Natera.

Which has the higher operating margin?

BeOne Medicines: 8.37%, against -13.4% for Natera. Operating margin is operating income as a share of revenue in the latest fiscal year.

Which superinvestors own both Natera and BeOne Medicines?

In their latest 13F filings, Temasek holds both.

Cite this page

Funkfolio, “Natera vs BeOne Medicines”, data as of 18 November 2026. https://funkfolio.com/compare/ntra-vs-onc

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.